Skip to content

Clinical trials

Phase 3 Hypertension trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Singapore Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20111
20171
20181
20192
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics2
AstraZeneca1
Boehringer Ingelheim1
CSL Behring1
Novartis1
Novartis Pharmaceuticals1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
The George Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension9
Cardiovascular Diseases5
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Hypertension, Pulmonary2
Lung Diseases2
Pulmonary Arterial Hypertension2
Renal Insufficiency, Chronic2
Respiratory Tract Diseases2
Stroke2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.